Histological and immunological characteristics of, and the effect of immunosuppressive treatment on, xenograft vasculopathy

Xenotransplantation

Volumn 11, Issue 2, 2004, Pages 149-159

  Briffa, Norman P ^a,b   Shorthouse, Randi ^a   Chan, Jason ^a   Silva, Helio ^a   Billingham, Margaret ^a   Brazelton, Timothy ^a   Morris, Randall E ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITALS COVENTRY AND WARWICKSHIRE NHS TRUST   (United Kingdom)

Author keywords

Aorta; Chronic rejection; Cyclosporin; Hamster; Leflunomide; Rat; Vasculopathy; Xenotransplantation

Indexed keywords

CD4 ANTIGEN; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C5A; CYCLINE; CYCLOSPORIN; DRUG METABOLITE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOSUPPRESSIVE AGENT; LEFLUNOMIDE; TERIFLUNOMIDE;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY TITER; AORTA GRAFT; ARTERY INTIMA PROLIFERATION; ARTERY LESION; ARTERY MEDIA; ARTICLE; CELL FREE SYSTEM; CHRONIC GRAFT REJECTION; COMPLEMENT DEPOSITION; COMPUTER ANALYSIS; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG EFFECT; DRUG METABOLISM; EXPERIMENTAL MODEL; EXPERIMENTAL TRANSPLANTATION; FLOW CYTOMETRY; GERMINAL CENTER; HAMSTER TO RAT AORTA TRANSPLANT MODEL; HISTOPATHOLOGY; HUMORAL IMMUNITY; IMMUNOFLUORESCENCE; IMMUNOGLOBULIN DEPOSITION; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; INTIMA; MACROPHAGE; MONOTHERAPY; MORPHOMETRICS; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; SEROLOGY; SPLEEN; SYRIAN HAMSTER; T LYMPHOCYTE SUBPOPULATION; VASCULAR DISEASE; XENOGRAFT; XENOGRAFT VASCULOPATHY; XENOTRANSPLANTATION;

ANIMALS; ANTIBODIES, HETEROPHILE; AORTA; CRICETINAE; CYCLOSPORINE; DRUG THERAPY, COMBINATION; IMMUNOSUPPRESSIVE AGENTS; ISOXAZOLES; MESOCRICETUS; RATS; RATS, INBRED LEW; RATS, NUDE; TISSUE AND ORGAN HARVESTING; TRANSPLANTATION, HETEROLOGOUS;

EID: 1442338594     PISSN: 0908665X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1399-3089.2003.00099.x     Document Type: Article

References (27)

1. COZZI E, WHITE DJ. Xenotransplantation. Curr Opin Nephrol Hypertens 1996; 5: 514.
2. KOBAYASHI T, TANIGUCHI S, NEETHLING FA et al. Delayed xenograft rejection of pig-to-baboon cardiac transplants after cobra venom factor therapy. Transplantation 1997; 64: 1255.
3. MIYAGAWA S, HIROSE H, SHIRAKURA R et al. The mechanism of discordant xenograft rejection. Transplantation 1988; 46: 825.
4. CANDINAS D, BACH FH, HANCOCK WW. Delayed xenograft rejection in complement-depleted T-cell deficient rat recipients of guinea pig cardiac grafts. Transplant Proc 1996;28:678.
5. AZUMA H, TILNEY NL. Immune and nonimmune mechanisms of chronic rejection of kidney allografts. J Heart Lung Transplant 1995; 14: S136.
6. VAN DEN BOGAERDE J, WHITE D, ROSER B, KAMPINGA J, ASPINALL R. In vitro and in vivo effects of monoclonal antibodies against T cell subsets on allogeneic and xenogeneic responses in the rat. Transplantation 1990; 50: 915.
7. LIN Y, VANDEPUTTE M, WAER M. Difference in tolerization of T-independent and T-dependent xenoantibody formation after cardiac xenotransplantation in rats. Transplant Proc 1996; 28: 741.
8. HASAN R, VAN DEN BOGAERDE JB, WALLWORK J, WHITE DJ. Evidence that long-term survival of concordant xenografts is achieved by inhibition of antispecies antibody production. Transplantation 1992; 54: 408.
9. MURASE N, STARZL TE, DEMETRIS AJ et al. Hamster-to-rat heart and liver xenotransplantation with FK506 plus antiproliferative drugs. Transplantation 1993; 55: 701.
10. XIAO F, CHONG AS, FOSTER P et al. Leflunomide controls rejection in hamster to rat cardiac xenografts. Transplantation 1994; 58: 828.
11. KARNOVSKY MJ, RUSSELL ME, HANCOCK W, SAYEGH MH, ADAMS DH. Chronic rejection in experimental cardiac transplantation in a rat model. Clin Transplant 1994; 8: 308.
12. HALTTUNEN J, PARTANEN T, LESZCZYNSKI D, RINTA K, HAYRY P. Rat aortic allografts: a model for chronic vascular rejection. Transplant Proc 1990; 22: 125.
13. SHEN J, CHONG AS, XIAO F et al. Histological characterization and pharmacological control of chronic rejection in xenogeneic and allogeneic heart transplantation. Transplantation 1998; 66: 692.
14. Yu CC, FILIPE MI. Update on proliferation-associated antibodies applicable to formalin-fixed paraffin-embedded tissue and their clinical applications. Histochem J 1993; 25: 843.
15. DIJKSTRA CD, DOPP EA, JOLING P, KRAAL G. The heterogeneity of mononuclear phagocytes in lymphoid organs: distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology 1985; 54: 589.
16. GOETZMAN EA. Flow cytometry: basic concepts and clinical applications in immunodiagnostics. Clin Lab Sci 1993; 6: 177.
17. REEMTSMA K, PIERSON RN, MARBOE CC et al. Will atherosclerosis limit clinical xenografting? Transplant Proc 1987; 19(Suppl. 5): 108.
18. O'HAIR DP, MCMANUS RP, KOMOROWSKI R. Inhibition of chronic vascular rejection in primate cardiac xenografts using mycophenolate mofetil. Ann Thorac Surg 1994; 58: 1311.
19. XIAO F, CHONG A, SHEN J et al. Pharmacologically induced regression of chronic transplant rejection. Transplantation 1995; 60: 1065.
20. LIN Y, VANDEPUTTE M, WAER M. Effect of leflunomide on T-independent xenoantibody formation in rats receiving hamster heart xenografts. Transplant Proc 1996; 28: 952.
21. SCHERINGA M, BUCHNER B, de BRUIN RW et al. Chronic rejection of concordant aortic xenografts in the hamster-to-rat model. Transplant Immunol 1996; 4: 192.
22. GOURLAY WA, CHAMBERS WH, MONACO AP, MAKI T. Importance of natural killer cells in the rejection of hamster skin xenografts. Transplantation 1998; 65: 727.
23. KORSGREN O. Acute cellular xenograft rejection. Xenotransplantation 1997; 1: 11.
24. IKEDA K, HIRANO M, TAKEUCHI M, YAMADA T, TOMIOKA K. Hamster cardiac xenograft in rat ear: effect of cyclosporine A and leflunomide on survival. Int J Immunopharmacol 1996; 18: 409.
25. SILVA JUNIOR HT, MORRIS RE. Leflunomide and malononitrilamides. Am J Med Sci 1997; 313: 289.
26. LIRTZMAN RA, GREGORY CR, LEVITSKI RE et al. Combined immunosuppression with leflunomide and cyclosporine prevents MLR-mismatched renal allograft rejection in a mongrel canine model. Transplant Proc 1996; 28: 945.
27. BALDWIN WM, PRUITT SK, BRAUER RB, DAHA MR, SANFILIPPO F. Complement in organ transplantation. Contributions to inflammation, injury, and rejection. Transplantation 1995; 59: 797.